Understanding how interactions between the central nervous system and the immune system contribute to problems of aging, including Alzheimer’s disease, Parkinson’s disease, arthritis, and more, can generate new leads for therapeutic development, speakers said at MIT’s symposium “The Neuro-Immune Axis and the Aging Brain” on Sept 18.
“The past decade has brought rapid progress in our understanding of how adaptive and innate immune systems impact the pathogenesis of neurodegenerative disorders,” said Picower Professor Li-Huei Tsai, director of The Picower Institute for Learning and Memory and MIT’s Aging Brain Initiative (ABI), in her introduction to the event, which more than 450 people registered to attend. “Together, today’s speakers will trace how the neuro-immune axis shapes brain health and disease … Their work converges on the promise of immunology-informed therapies to slow or prevent neurodegeneration and age-related cognitive decline.”
For instance, keynote speaker Michal Schwartz of the Weizmann Institute in Israel described her decades of pioneering work to understand the neuro-immune “ecosystem.” Immune cells,